Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer
      Biotech

      Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer

      January 13, 2025
      Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
      Biotech

      Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program

      January 13, 2025
      Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb).
      Biotech

      Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb).

      January 13, 2025
      FDA Roundup: January 10, 2025
      Biotech

      FDA Roundup: January 10, 2025

      January 13, 2025
      Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio
      Biotech

      Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio

      January 13, 2025
      JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma
      Biotech

      JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma

      January 13, 2025
      Alchemab Therapeutics enters into collaboration with Lilly to discover, research and develop novel therapies for ALS
      Biotech

      Alchemab Therapeutics enters into collaboration with Lilly to discover, research and develop novel therapies for ALS

      January 9, 2025
      Ventris Medical Receives 510(k) Clearance for Innovative Backpack® Bone Graft Containment System
      Biotech

      Ventris Medical Receives 510(k) Clearance for Innovative Backpack® Bone Graft Containment System

      January 9, 2025
      Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
      Biotech

      Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics

      January 8, 2025
      Vesper Bio initiates Phase Ib/IIa proof of concept study of VES001 in asymptomatic patients with gene mutations that cause frontotemporal dementia (FTD)
      Biotech

      Vesper Bio initiates Phase Ib/IIa proof of concept study of VES001 in asymptomatic patients with gene mutations that cause frontotemporal dementia (FTD)

      January 7, 2025
      « 1 … 55 56 57 58 59 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026